Fulcrum Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $257.7M
Liabilities Breakdown FY2023
Total Liabilities: $22.5M
Asset Breakdown
Total Assets: $257.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $25.6M | 9.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.2M | 2.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $226.9M | 88.1% |
Liabilities Breakdown
Total Liabilities: $22.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.8M | 12.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $19.7M | 87.7% |